Scientific Advisory Board

The Institute's Scientific Advisory Board meets every 18 months to discuss our strategy and progress with the Director, Deputy Director and other members of the senior management team.

Scientific Advisory Board

David Adams (Chair)

Sanger Institute, UK

Simon Barry

AstraZeneca, Cambridge, UK

Karin de Visser

NKI, Amsterdam, The Netherlands

Rebecca Fitzgerald

University of Cambridge, UK

Karuna Ganesh

Sloan Kettering Institute, New York, USA

Johanna Ivaska

University of Turku, Finland

Louise Jones

Barts Cancer Institute, London, UK

Jos Jonkers

NKI, Amsterdam, The Netherlands

Alec Kimmelman

NYU Langone Health, New York, USA

John Marioni

Genentech, San Francisco, USA

Ultan McDermott

AstraZeneca, Cambridge, UK